tetano
Editor, Senior Moderator
Avicenna J Med Biotechnol
. Jan-Mar 2022;14(1):3-9.
doi: 10.18502/ajmb.v14i1.8165.
CRISPR-Cas System: A Promising Diagnostic Tool for Covid-19
Saeedeh Ebrahimi[SUP] 1 [/SUP], Hashem Khanbabaei[SUP] 2 [/SUP], Samaneh Abbasi[SUP] 3 [/SUP], Mona Fani[SUP] 4 [/SUP], Saber Soltani[SUP] 5 [/SUP], Milad Zandi[SUP] 5 [/SUP], Zahra Najafimemar[SUP] 6 [/SUP]
Affiliations
Abstract
More than a year has passed since the beginning of the 2019 novel coronavirus diseases (COVID-19) pandemic which has created massive problems globally affecting all aspects of people's life. Due to the emergence of new strains of the SARS-CoV-2, pandemic risk still remains, despite the start of vaccination. Therefore, rapid diagnostic tests are essential to control infection, improve clinical care and stop the spread of the disease. Recently CRISPR-based diagnostic tools have facilitated rapid diagnostic. Here, we review the diagnostic applications of CRISPR-Cas system in COVID-19.
Keywords: COVID-19; CRISPR-Cas systems; SARS-CoV-2.
. Jan-Mar 2022;14(1):3-9.
doi: 10.18502/ajmb.v14i1.8165.
CRISPR-Cas System: A Promising Diagnostic Tool for Covid-19
Saeedeh Ebrahimi[SUP] 1 [/SUP], Hashem Khanbabaei[SUP] 2 [/SUP], Samaneh Abbasi[SUP] 3 [/SUP], Mona Fani[SUP] 4 [/SUP], Saber Soltani[SUP] 5 [/SUP], Milad Zandi[SUP] 5 [/SUP], Zahra Najafimemar[SUP] 6 [/SUP]
Affiliations
- PMID: 35509363
- PMCID: PMC9017467
- DOI: 10.18502/ajmb.v14i1.8165
Abstract
More than a year has passed since the beginning of the 2019 novel coronavirus diseases (COVID-19) pandemic which has created massive problems globally affecting all aspects of people's life. Due to the emergence of new strains of the SARS-CoV-2, pandemic risk still remains, despite the start of vaccination. Therefore, rapid diagnostic tests are essential to control infection, improve clinical care and stop the spread of the disease. Recently CRISPR-based diagnostic tools have facilitated rapid diagnostic. Here, we review the diagnostic applications of CRISPR-Cas system in COVID-19.
Keywords: COVID-19; CRISPR-Cas systems; SARS-CoV-2.